Hepatocyte growth factor receptor 3D structures: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
*Hepatocyte growth factor receptor ; Domains – SEMA 25-564; ψ 519-562; Ig1, Met741 565-740;tyrosine kinase 1041-1378 | *Hepatocyte growth factor receptor ; Domains – α chain 125-311; SEMA 25-564; ψ 519-562; Ig1, Met741 565-740;tyrosine kinase 1041-1378 | ||
**[[1ssl]] – hHGFR ψ domain – human - NMR <br /> | **[[1ssl]] – hHGFR ψ domain – human - NMR <br /> | ||
**[[3q6u]], [[2g15]] – hHGFR tyrosine kinase domain<br /> | **[[3q6u]], [[2g15]] – hHGFR tyrosine kinase domain<br /> | ||
**[[3dkc]], [[3dkf]], [[3dkg]], [[1r1w]] – hHGFR tyrosine kinase domain (mutant) <br /> | **[[3dkc]], [[3dkf]], [[3dkg]], [[1r1w]] – hHGFR tyrosine kinase domain (mutant) <br /> | ||
**[[7ocl]], [[7ocm]] – hHGFR α chain<br /> | |||
*HGFR complex | *HGFR complex | ||
**[[7mo7]], [[7mo8]], [[7mo9]], [[7moa]], [[7mob]] – hHGFR + hHGF – Cryo EM <br /> | |||
**[[1r0p]] – hHGFR tyrosine kinase domain (mutant) + K-252A <br /> | **[[1r0p]] – hHGFR tyrosine kinase domain (mutant) + K-252A <br /> | ||
**[[2uzx]], [[2uzy]] – hHGFR SEMA, ψ, Ig1, Met741 domains + internalin B <br /> | **[[2uzx]], [[2uzy]] – hHGFR SEMA, ψ, Ig1, Met741 domains + internalin B <br /> | ||
**[[6gcu]] – hHGFR SEMA, ψ, Ig1, Met741 domains + internalin B + darpin<br /> | **[[6gcu]] – hHGFR SEMA, ψ, Ig1, Met741 domains + internalin B + darpin<br /> | ||
**[[2rfn]], [[2rfs]], [[3ccn]], [[3cd8]], [[3f66]], [[2wd1]], [[2wgj]], [[3l8v]], [[3lq8]], [[2wkm]], [[3q6w]], [[3rhk]], [[3qti]], [[3zxz]], [[3zze]], [[3r7o]], [[3u6h]], [[3u6i]], [[4deg]], [[4deh]], [[4dei]], [[4aoi]], [[4ap7]], [[4gg5]], [[4gg7]], [[4eev]], [[4knb]], [[4mxc]], [[4r1v]], [[4r1y]], [[4xmo]], [[4xyf]], [[5dg5]], [[5eob]], [[5eyc]], [[5eyd]], [[5hni]], [[5hti]], [[5t3q]], [[5uab]], [[5uad]], [[6ubw]], [[5ya5]] – hHGFR tyrosine kinase domain + inhibitor <br /> | **[[2rfn]], [[2rfs]], [[3ccn]], [[3cd8]], [[3f66]], [[2wd1]], [[2wgj]], [[3l8v]], [[3lq8]], [[2wkm]], [[3q6w]], [[3rhk]], [[3qti]], [[3zxz]], [[3zze]], [[3r7o]], [[3u6h]], [[3u6i]], [[4deg]], [[4deh]], [[4dei]], [[4aoi]], [[4ap7]], [[4gg5]], [[4gg7]], [[4eev]], [[4knb]], [[4mxc]], [[4r1v]], [[4r1y]], [[4xmo]], [[4xyf]], [[5dg5]], [[5eob]], [[5eyc]], [[5eyd]], [[5hni]], [[5hti]], [[5t3q]], [[5uab]], [[5uad]], [[6ubw]], [[5ya5]], [[6ubw]], [[7b3q]], [[7b3t]], [[7b3v]], [[7b3w]], [[7b3z]], [[7b40]], [[7b41]], [[7b42]], [[7b43]], [[7b44]] – hHGFR tyrosine kinase domain + inhibitor <br /> | ||
**[[3c1x]], [[3cth]], [[3ctj]], [[3ce3]], [[3efj]], [[3efk]], [[3f82]], [[3i5n]], [[3a4p]], [[5hlw]], [[5ho6]], [[5hoa]], [[5hor]], [[6sdd]] – hHGFR tyrosine kinase domain (mutant) + inhibitor <br /> | **[[3c1x]], [[3cth]], [[3ctj]], [[3ce3]], [[3efj]], [[3efk]], [[3f82]], [[3i5n]], [[3a4p]], [[5hlw]], [[5ho6]], [[5hoa]], [[5hor]], [[6sdd]] – hHGFR tyrosine kinase domain (mutant) + inhibitor <br /> | ||
**[[6sd9]], [[6sde]] – hHGFR tyrosine kinase domain + cancer drug<br /> | **[[6sd9]], [[6sde]] – hHGFR tyrosine kinase domain + cancer drug<br /> | ||
| Line 22: | Line 24: | ||
**[[4o3t]], [[4o3u]] – hHGFR SEMA and ψ domain (mutant) + hHGF α chain (mutant) + zymogen activator peptide<br /> | **[[4o3t]], [[4o3u]] – hHGFR SEMA and ψ domain (mutant) + hHGF α chain (mutant) + zymogen activator peptide<br /> | ||
**[[3vw8]], [[3zbx]], [[3zc5]], [[3zcl]], [[4iwd]] - hHGFR tyrosine kinase domain + inhibitor<br /> | **[[3vw8]], [[3zbx]], [[3zc5]], [[3zcl]], [[4iwd]] - hHGFR tyrosine kinase domain + inhibitor<br /> | ||
**[[6i04]] – hHGFR SEMA domain + antibody <br /> | **[[6i04]], [[6wvz]] – hHGFR SEMA domain + antibody <br /> | ||
**[[5lsp]] – hHGFR ψ, Ig1, Met741 domains + antibody<br /> | **[[5lsp]] – hHGFR ψ, Ig1, Met741 domains + antibody<br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||